Rapid PE Triage and Notification (PETN) vs ElucidVivo A.3

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

Tool A, Rapid PE Triage and Notification, is designed for the rapid identification and notification of acute pulmonary embolisms from CTPA images, streamlining emergency care. In contrast, Tool B, ElucidVivo A.3, focuses on the quantitative analysis of arterial plaque composition from CT angiography to aid in chronic atherosclerosis patient stratification and treatment optimization. While both leverage AI for cardiovascular imaging analysis, their distinct clinical applications for acute PE versus chronic arterial plaque make them adjacent rather than direct competitors.

Choose Rapid PE Triage and Notification (PETN) if…

Choose Rapid PE Triage and Notification (PETN) if your primary need is to rapidly identify and prioritize suspected central pulmonary embolisms from CTPA images in acute care settings. This tool is ideal for emergency departments and critical care units aiming to accelerate diagnosis and streamline the care pathway for patients with potential life-threatening PEs through real-time clinician notifications.

View Rapid PE Triage and Notification (PETN) →

Choose ElucidVivo A.3 if…

Choose ElucidVivo A.3 if your focus is on detailed, quantitative analysis of arterial plaque composition and stability to stratify atherosclerosis patients and optimize long-term treatment decisions. This system is best suited for cardiologists, radiologists, and vascular surgeons who require precise measurements of plaque characteristics, including lipid-rich necrotic core, to assess cardiovascular risk beyond simple stenosis.

View ElucidVivo A.3 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Rapid PE Triage and Notification (PETN) ElucidVivo A.3
Pricing Contact for pricing Unknown
Deployment On-premise Rapid Server (dedicated or virtual) within hospital LAN/firewall, or Rapid Edge Cloud Platform. Cloud and on-premise secure deployment.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rapid PE Triage and Notification (PETN)

Rapid PE Triage and Notification (Tool A) prioritizes rapid, actionable alerts with real-time notifications to clinicians via PACS, email, and mobile apps, facilitating immediate workflow triage. Its mobile and desktop application access is designed for quick review and coordination of care for acute conditions. ElucidVivo A.3 (Tool B), while powerful in its detailed visualization, appears to be a more specialized analytical tool that may involve a steeper learning curve for its in-depth plaque analysis.

Clinical Value

ElucidVivo A.3

ElucidVivo A.3 (Tool B) offers profound clinical value by providing histology-validated quantitative analysis of arterial plaque composition and stability, including the derivation of fractional flow reserve (FFRct), which aids in atherosclerosis patient stratification and treatment optimization. It has demonstrated a 40% improvement in predictive accuracy for major adverse neurologic events compared to stenosis alone. While Rapid PE Triage and Notification (Tool A) is critical for acute PE detection, ElucidVivo A.3 provides deeper, prognostically valuable insights for long-term disease management.

Pricing & Value

ElucidVivo A.3

Both tools require direct contact for pricing, making a direct cost comparison impossible. However, ElucidVivo A.3 (Tool B) has recently secured broad reimbursement from CMS and private payors for its coronary plaque analysis, including a new Category I CPTu00ae designation, effective January 1, 2026. This established reimbursement pathway indicates a recognized and favorable financial value proposition within the healthcare system, which is not explicitly detailed for Tool A.

Enterprise Readiness

Rapid PE Triage and Notification (PETN)

Rapid PE Triage and Notification (Tool A) explicitly states HIPAA compliance and Business Associate Agreement (BAA) availability, and offers flexible deployment options including on-premise or cloud platforms. ElucidVivo A.3 (Tool B) only implies HIPAA compliance and BAA availability, with comparative analyses often listing these as 'unknown.' Tool A's explicit compliance statements and detailed deployment options demonstrate a more transparent and confirmed enterprise readiness.

Innovation

ElucidVivo A.3

ElucidVivo A.3 (Tool B) demonstrates greater innovation through its AI-powered, histology-validated quantitative analysis of arterial plaque composition and stability, including the objective quantification of specific plaque components and the derivation of FFRct. This provides an unprecedented depth of insight into atherosclerosis for personalized management. Rapid PE Triage and Notification (Tool A) focuses on rapid detection and notification for acute conditions, which is valuable but less complex in its analytical depth.

Support & Docs

Rapid PE Triage and Notification (PETN)

RapidAI, the company behind Rapid PE Triage and Notification (Tool A), explicitly offers 24/7/365 customer support via email and phone, with a multilingual technical services team. They also provide educational resources and documentation. In contrast, the provided information and web searches for ElucidVivo A.3 (Tool B) do not detail specific customer support channels, operating hours, or comprehensive documentation availability.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Rapid PE Triage and Notification (PETN) ElucidVivo A.3
Tool Name Rapid PE Triage and Notification (PETN) ElucidVivo A.3
Company RapidAI (formerly iSchemaView) Elucid Bioimaging
Primary Function Rapidly identifies and notifies clinicians of suspected central pulmonary embolisms from CTPA images. Provides quantitative analysis of arterial plaque composition and stability from CT angiography.
Key Features (Tool A specific) Detection of suspected central pulmonary embolism (PE), Workflow triage and prioritization, Real-time notifications to clinicians (PACS, email, mobile app) Not applicable
Key Features (Tool B specific) Not applicable Objectively quantifies Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications from CT images, Visualizes lesion-level plaque composition, Derives fractional flow reserve (FFRct) based on vessel wall vasodilative capacity
Specialties Cardiology, Emergency Medicine, Radiology Cardiology, Radiology, Vascular Surgery

Videos

Demos, reviews, and walkthroughs featuring Rapid PE Triage and Notification (PETN) and ElucidVivo A.3.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Rapid PE Triage and Notification (PETN) is designed to rapidly identify and notify clinicians of suspected central pulmonary embolisms from CTPA images, streamlining workflow and accelerating patient care pathways. ElucidVivo A.3 provides quantitative analysis of arterial plaque composition and stability from CT angiography to assist physicians in atherosclerosis patient stratification and optimize treatment decisions.
Rapid PE Triage and Notification (PETN) analyzes CTPA images for the detection of suspected central pulmonary embolism. ElucidVivo A.3 performs quantitative analysis of arterial plaque composition and stability from CT angiography.
Rapid PE Triage and Notification (PETN) operates in parallel with standard of care, providing real-time notifications to clinicians via PACS, email, and a mobile app for workflow triage and prioritization. ElucidVivo A.3 is a software application that integrates with PACS/EMR, assisting physicians by offering detailed visualization and measurement of plaque characteristics.
Rapid PE Triage and Notification (PETN) provides detection of suspected central pulmonary embolism and workflow triage and prioritization. ElucidVivo A.3 objectively quantifies Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications, visualizes lesion-level plaque composition, and derives fractional flow reserve (FFRct) based on vessel wall vasodilative capacity.
Rapid PE Triage and Notification (PETN) is primarily intended for Cardiology, Emergency Medicine, and Radiology. ElucidVivo A.3 is designed for Cardiology, Radiology, and Vascular Surgery.
AI Tool Finder
AI-powered search. Results may not be comprehensive.